SAN FRANCISCO (AP) — Charlotte Mailliard Shultz, the long-reigning chief of San Francisco protocol and unofficial aide to 10 mayors, died Friday of complications from cancer. She was 88.
WASHINGTON (AP) — Sen. Bernie Sanders is asking the White House to cut back a big Medicare premium hike set to take effect in weeks and tied to a pricey Alzheimer's drug whose benefits have been widely questioned.
GENEVA (AP) — The World Health Organization says it could still take some time to get a full picture of the threat posed by omicron, a new variant of the coronavirus as scientists worldwide scramble to assess its multiple mutations.
WASHINGTON (AP) — Holiday decorations unveiled Monday for Joe and Jill Biden’s first White House Christmas honor frontline workers who persevered during the COVID-19 pandemic.
BUDAPEST, Hungary (AP) — From appliance stores in the United States to food markets in Hungary and gas stations in Poland, rising consumer prices fueled by high energy costs and supply chain disruptions are putting a pinch on households and
PRETORIA, South Africa (AP) — The overcast, drizzly skies match the somber mood at the Tshwane University of Technology, a hot spot in South Africa’s latest surge of COVID-19 cases, apparently driven by the new omicron variant that is leading
Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.
ABINGDON, Va. (AP) — For 26 years, Ernest Ray worked at a company in southwest Virginia that made compressors, in a physically demanding job that involved night shifts on a factory floor. When the plant closed in 2018, Ray applied
FRANKFURT, Germany (AP) — The holiday tree is towering over the main square in this central German city, the chestnuts and sugared almonds are roasted, and kids are clambering aboard the merry-go-round just like they did before the pandemic. But
AMSTERDAM (AP) — The European Medicines Agency says it is evaluating whether to authorize booster doses of Johnson & Johnson's single-shot COVID-19 vaccine.